×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CMRX – chimerix, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CMRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/31
02:08 am
cmrx
Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/26
08:13 pm
cmrx
Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 [Yahoo! Finance]
Low
Report
Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 [Yahoo! Finance]
3/23
02:05 am
cmrx
Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/21
06:00 am
cmrx
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
Low
Report
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
3/17
12:45 pm
cmrx
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA, CKPT on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA, CKPT on Behalf of Shareholders
3/15
02:05 am
cmrx
Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/11
03:05 pm
cmrx
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA on Behalf of Shareholders
3/11
02:20 pm
cmrx
Kuehn Law Encourages BRDG, CMRX, WBA and SYTA Investors to Contact Law Firm
Low
Report
Kuehn Law Encourages BRDG, CMRX, WBA and SYTA Investors to Contact Law Firm
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/1
04:25 pm
cmrx
Form SC TO-T/A CHIMERIX INC Filed by: Jazz Pharmaceuticals plc
Neutral
Report
Form SC TO-T/A CHIMERIX INC Filed by: Jazz Pharmaceuticals plc
4/1
04:16 pm
cmrx
Form SC 14D9/A CHIMERIX INC Filed by: CHIMERIX INC
Low
Report
Form SC 14D9/A CHIMERIX INC Filed by: CHIMERIX INC
3/28
08:35 am
cmrx
Form SC TO-T/A CHIMERIX INC Filed by: Jazz Pharmaceuticals plc
Low
Report
Form SC TO-T/A CHIMERIX INC Filed by: Jazz Pharmaceuticals plc
3/21
07:33 am
cmrx
Form SC 14D9 CHIMERIX INC Filed by: CHIMERIX INC
Low
Report
Form SC 14D9 CHIMERIX INC Filed by: CHIMERIX INC
3/21
06:54 am
cmrx
Form SC TO-T CHIMERIX INC Filed by: Jazz Pharmaceuticals plc
Low
Report
Form SC TO-T CHIMERIX INC Filed by: Jazz Pharmaceuticals plc
3/21
06:36 am
cmrx
Form 10-K CHIMERIX INC For: Dec 31
Low
Report
Form 10-K CHIMERIX INC For: Dec 31
3/21
06:06 am
cmrx
Form 8-K CHIMERIX INC For: Mar 21
Low
Report
Form 8-K CHIMERIX INC For: Mar 21
3/6
04:49 pm
cmrx
Form SC TO-C CHIMERIX INC Filed by: Jazz Pharmaceuticals plc
Low
Report
Form SC TO-C CHIMERIX INC Filed by: Jazz Pharmaceuticals plc
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/28
Chimerix Receives FDA Clearance for Rolling Submission of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox
37.8%
2/25 Q4/2019 12/31/2019 EPS -0.060 ZacksConsensus -0.170 ActVsEst 0.110 - Beat 15.6%
3/24 Form 8-K CHIMERIX INC For: Mar 18 12.3%
12/10 Form SC 13G/A CHIMERIX INC Filed by: ArrowMark Colorado Holdings LLC 10.7%
5/9 Chimerix's (CMRX) CEO Mark Iwicki on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] 8.7%
11/4 Chimerix to Present at Upcoming Investor Conferences 8.2%
5/13 Form 4 CHIMERIX INC For: May 10 Filed by: MIDDLETON FRED A 7.6%
1/7 Chimerix Inc (NASDAQ: CMRX) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 7.4%
5/10 Chimerix Inc (NASDAQ: CMRX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 5.4%
2/14 Form SC 13G/A CHIMERIX INC Filed by: Redmile Group, LLC 5.4%
2/25 Q4/2019 12/31/2019 EPS -0.060 ZacksConsensus -0.170 ActVsEst 0.110 - Beat 15.6%
3/24 Form 8-K CHIMERIX INC For: Mar 18 12.3%
12/10 Form SC 13G/A CHIMERIX INC Filed by: ArrowMark Colorado Holdings LLC 10.7%
5/9 Chimerix's (CMRX) CEO Mark Iwicki on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] 8.7%
11/4 Chimerix to Present at Upcoming Investor Conferences 8.2%
5/13 Form 4 CHIMERIX INC For: May 10 Filed by: MIDDLETON FRED A 7.6%
1/7 Chimerix Inc (NASDAQ: CMRX) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 7.4%
5/10 Chimerix Inc (NASDAQ: CMRX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 5.4%
2/14 Form SC 13G/A CHIMERIX INC Filed by: Redmile Group, LLC 5.4%
TOP News Decliners
12/10
Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting
-26.0%
9/30 Chimerix Announces Exclusive Global License Agreement with SymBio Pharmaceuticals for Brincidofovir -12.5%
1/29 Chimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox at 2020 American Society for Microbiology Biothreats Meeting -9.3%
2/25 Form 3 CHIMERIX INC For: Feb 21 Filed by: Multani Pratik S -7.0%
2/24 Form 8-K CHIMERIX INC For: Feb 21 -4.9%
8/1 Chimerix Inc (NASDAQ: CMRX) had its price target raised by analysts at HC Wainwright from $5.00 to $7.00. They now have a "buy" rating on the stock. -4.6%
9/2 Chimerix Inc (NASDAQ: CMRX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -4.5%
1/23 Form 4 CHIMERIX INC For: Jan 21 Filed by: Jakeman David -4.0%
10/3 Form 8-K CHIMERIX INC For: Sep 30 -4.0%
7/31 Form D CHIMERIX INC -3.9%
9/30 Chimerix Announces Exclusive Global License Agreement with SymBio Pharmaceuticals for Brincidofovir -12.5%
1/29 Chimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox at 2020 American Society for Microbiology Biothreats Meeting -9.3%
2/25 Form 3 CHIMERIX INC For: Feb 21 Filed by: Multani Pratik S -7.0%
2/24 Form 8-K CHIMERIX INC For: Feb 21 -4.9%
8/1 Chimerix Inc (NASDAQ: CMRX) had its price target raised by analysts at HC Wainwright from $5.00 to $7.00. They now have a "buy" rating on the stock. -4.6%
9/2 Chimerix Inc (NASDAQ: CMRX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -4.5%
1/23 Form 4 CHIMERIX INC For: Jan 21 Filed by: Jakeman David -4.0%
10/3 Form 8-K CHIMERIX INC For: Sep 30 -4.0%
7/31 Form D CHIMERIX INC -3.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: